Colchester, VT, United States of America

Patrick Finbar McGarry



Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Mountain View, CA (US) (2007)
  • Colchester, VT (US) (2010)

Company Filing History:


Years Active: 2007-2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Patrick Finbar McGarry

Introduction

Patrick Finbar McGarry is a notable inventor based in Colchester, Vermont, USA. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. With a total of 2 patents, McGarry's work has implications for medical treatments and drug development.

Latest Patents

McGarry's latest patents include a "Process for synthesis of phenoxy diaminopyrimidine derivatives." This method involves treating a compound with an iodination reagent to form a new compound, which has potential applications in various chemical processes. Another significant patent is for "Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists." This patent describes compounds that can be used to treat conditions associated with the activity of alpha-1A/B adrenoceptors, showcasing McGarry's focus on developing therapeutic agents.

Career Highlights

Throughout his career, McGarry has worked with prominent companies in the pharmaceutical industry, including Roche Palo Alto LLC and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to contribute to groundbreaking research and development in drug formulation and synthesis.

Collaborations

Some of McGarry's notable coworkers include Anton Constantinescu and Keena Lynn Green. Their collaborative efforts have likely enhanced the innovative processes and research outcomes in which they have been involved.

Conclusion

Patrick Finbar McGarry's contributions to the field of chemistry and pharmaceuticals are noteworthy. His patents reflect a commitment to advancing medical science through innovative solutions. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…